INVICTUS COMPLETES LEAF WISE ACQUISITION
November 02 2018 - 7:53AM
InvestorsHub NewsWire
INVICTUS COMPLETES LEAF WISE
ACQUISITION
Vancouver, BC -- November 02, 2018 --
InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus"
or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)
today announced
the completion of its previously announced definitive agreement to
acquire 100% (the “Acquisition”) of the issued and
outstanding shares of a company ("Leaf Wise”) that
operates medical clinics in Alberta (see press releases dated July
20, 2018 and October 25, 2018 for more details). The Acquisition
was approved by the Board and TSXV on October 31,
2018.
For more information, please visit
www.invictus-md.com.
On Behalf of the
Board,
Dan
Kriznic
Chairman and
CEO
Jessica
Martin
Vice President, Public Relations and
Regulatory Affairs
(833)
879-4363
About
Invictus
Invictus is a global cannabis
company offering a selection of products under a wide range of
lifestyle brands. Our integrated sales approach is defined by five
pillars of distribution including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores.
Invictus has partnered with business
leaders to convey our corporate vision, including KISS music legend
and business mogul Gene Simmons as our Chief Evangelist Officer. To
meet growing demand, Invictus is expanding its cultivation
footprint, with two cannabis production facilities fully licensed
under ACMPR in Canada and a third awaiting approval, featuring
100,000 square feet of available grow space today with 200,000
expected by January 2019 and up to 1 million by end of 2020. To
accommodate international sales, Invictus’ wholly-owned subsidiary,
Acreage Pharms Ltd. (“Acreage Pharms”), has designed and is
currently building its Phase 3 and 4 purpose-built cultivation
facilities to be European Union Good Manufacturing Practices
(“EU-GMP”) compliant. The Company will earmark up to 50 per cent of
production to the medical. To ensure consistency in quality and
supply, Invictus maintains all aspects of the growing process
through its subsidiary, Future Harvest Development Ltd., a
high-quality Fertilizer and Nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 69 Health Canada approved strains and a
multifaceted distribution strategy including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. For more information visit
www.invictus-md.com.
Cautionary
Note Regarding Forward-Looking Statements: This release includes
certain statements and information that may constitute
forward-looking information within the meaning of applicable
Canadian securities laws or forward-looking statements within the
meaning of the United States Private Securities Litigation Reform
Act of 1995. All statements in this news release, other than
statements of historical facts, including statements regarding
future estimates, plans, objectives, timing, assumptions or
expectations of future performance, including the potential
production capacity of Invictus, are forward-looking statements and
contain forward-looking information. Generally, forward-looking
statements and information can be identified by the use of
forward-looking terminology such as “intends” or “anticipates”, or
variations of such words and phrases or statements that certain
actions, events or results “may”, “could”, “should”, “would” or
“occur”. Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that Invictus will be successful in reaching its
potential production capacity, its production facilities will be
completed as anticipated, regulatory approval will be granted as
anticipated, Invictus will reach full production capacity on the
timeline anticipated by the Company, and no unforeseen
construction delays will be experienced. These forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, Invictus will not be successful in reaching its
potential production capacity, its production facilities will not
be completed as anticipated, and licenses or approvals being
granted on terms or timelines that are materially worse than
expected by the Company. Although management of the Company has
attempted to identify important factors that could cause actual
results to differ materially from those contained in
forward-looking statements or forward-looking information, there
may be other factors that cause results not to be as anticipated,
estimated or intended. There can be no assurance that such
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on
forward-looking statements and forward-looking information. Readers
are cautioned that reliance on such information may not be
appropriate for other purposes. The Company does not undertake to
update any forward-looking statement, forward-looking information
or financial out-look that are incorporated by reference herein,
except in accordance with applicable securities
laws.
Neither
the TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Sep 2023 to Sep 2024